日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial

对既往预防性治疗失败且自述合并精神疾病的偏头痛患者,依普汀单抗的持续疗效:安慰剂对照 DELIVER 试验的事后分析

Pozo-Rosich, Patricia; Tassorelli, Cristina; Boserup, Line Pickering; Awad, Susanne F; Lee, Xin Ying; Ailani, Jessica

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study

研究参与者对STS101(二氢麦角胺鼻粉)的使用印象和满意度:来自开放标签ASCEND急性偏头痛研究的结果

Ailani, Jessica; Charleston, Larry 4th; Strom, Shannon; Albrecht, Detlef; Cowan, Robert

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) study

患者不愿服用偏头痛预防药物的原因:OVERCOME(美国)研究的结果

Ailani, Jessica; Okonkwo, Rose; Johnston, Elizabeth; Hochstetler, Helen; Martinez, Betzaida; Zagar, Anthony; Nicholson, Robert A; Vargas, Bert B; Muenzel, E Jolanda; Lipton, Richard B

Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed

对于接受依普汀单抗治疗且既往2-4种预防性治疗均失败的偏头痛患者,在初始偏头痛缓解后可观察到长期改善

Ailani, Jessica; Ashina, Messoud; Awad, Susanne F; Lee, Xin Ying; Boserup, Line Pickering; Soni-Brahmbhatt, Seema; Sperling, Bjørn; Lipton, Richard B

Androgen receptor expression in glioblastoma: molecular profiling and association with tumor burden

胶质母细胞瘤中雄激素受体表达:分子谱分析及其与肿瘤负荷的关联

Liubych, Larysa; Hahn, Lorenz; Hollnagel, Raja; Streubel, Maria Karolin; Ailani, Deepak; Leppert, Jan; Krenzlin, Harald; Matschke, Jakob; Soltwedel, Celina; Borgardt, Nicole; Behling, Susanne; Zemskova, Oksana; Ditz, Claudia; Gebauer, Niklas; Kebenko, Maxim; Keric, Naureen; Lapshyna, Olga; Gemoll, Timo; Carl, Cedric; Neumann, Alexander; Rades, Dirk; Löser, Anastassia

Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial

Ubrogepant治疗偏头痛前驱症状:来自随机3期PRODROME试验的探索性分析

Goadsby, Peter J; Ailani, Jessica; Dodick, David W; Starling, Amaal J; Liu, Chengcheng; Liu, Yingyi; Yu, Sung Yun; Smith, Jonathan H; Brand-Schieber, Elimor; Trugman, Joel M

Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial

接受扎维泮治疗的患者疼痛和功能障碍随时间推移而减轻:BHV3500-301 3期随机对照试验的事后分析

Powell, Lauren; O'Sullivan, Fiona; Jayasinghe, Pramoda; Rogula, Basia; Dai, Feng; Cirillo, Jessica; Sweeney, Samantha; Abraham, Lucy; Ailani, Jessica

Measuring incremental burdens associated with increasing preventive-treatment failures among adults with migraine: a retrospective, cross-sectional study

衡量偏头痛成人患者预防性治疗失败率增加所带来的额外负担:一项回顾性横断面研究

Ailani, Jessica; Chen, Nemin; Patel, Avani; Spence, Nathan; Sternbach, Nikoletta; Tellor, Katie B; Lewis, Motomori; Brown, Joshua

State of the art in the management of migraine-A response to the American College of Physicians migraine preventive treatment guideline

偏头痛治疗的最新进展——对美国内科医师学会偏头痛预防治疗指南的回应

Charles, Andrew C; Tepper, Stewart J; Ailani, Jessica

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study

依瑞奈单抗与其他偏头痛预防药物对心血管和脑血管结局的影响:一项基于美国医疗保险数据库的观察性队列研究

Dodick, David W; Tepper, Stewart J; Ailani, Jessica; Khodavirdi, Ani C; Pannacciulli, Nico; Fu, Alan; Kent, Shia T; Gill, Karminder; Urman, Robert; Oh, Sam S